Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists? The following represents disclosure information ...
Luteinizing hormone (LH) is a key regulator of follicular maturation, oocyte release and corpus luteum function, operating within the hypothalamic–pituitary–ovarian axis. In assisted reproductive ...
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma A total of 501 patients were included in the analysis: 287 received ...
Melatonin Effects on Luteinizing Hormone in Postmenopausal Women: A Pilot Clinical Trial NCT00288262
The 20 participants completing the study had a mean age of 59 years (range 51–69). As expected due to random group assignment, baseline values of urinary LH excretion among the 3 groups were not ...
New research shows men with very low testosterone levels are at higher risk of both fatal and nonfatal cancer later in life.
The luteinizing hormone receptor (LHR) is a G protein-coupled receptor whose dynamic expression in ovarian granulosa and theca cells underpins key events in folliculogenesis, ovulation and luteal ...
Your doctor may prescribe hormone therapy if you have late-stage cancer and sometimes if you have working ovaries and want to get pregnant. Photo Credit: iStock/Getty Images Hormone therapy for ...
Melatonin Effects on Luteinizing Hormone in Postmenopausal Women: A Pilot Clinical Trial NCT00288262
Background: In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results